Rank | Gene Set | Z-score |
---|---|---|
1 | proline transport (GO:0015824) | 5.88560294 |
2 | regulation of sequestering of triglyceride (GO:0010889) | 5.74017342 |
3 | triglyceride catabolic process (GO:0019433) | 5.36734602 |
4 | white fat cell differentiation (GO:0050872) | 5.28778822 |
5 | low-density lipoprotein particle clearance (GO:0034383) | 5.15088921 |
6 | regulation of platelet aggregation (GO:0090330) | 5.11338824 |
7 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 5.05945232 |
8 | thrombin receptor signaling pathway (GO:0070493) | 5.02229051 |
9 | carnitine shuttle (GO:0006853) | 4.94397914 |
10 | negative regulation of norepinephrine secretion (GO:0010700) | 4.90378757 |
11 | neutral lipid catabolic process (GO:0046461) | 4.86362075 |
12 | acylglycerol catabolic process (GO:0046464) | 4.86362075 |
13 | fatty acid transmembrane transport (GO:1902001) | 4.67595594 |
14 | brown fat cell differentiation (GO:0050873) | 4.65238377 |
15 | nerve growth factor signaling pathway (GO:0038180) | 4.55953838 |
16 | * regulation of cAMP-dependent protein kinase activity (GO:2000479) | 4.52485588 |
17 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.45322936 |
18 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 4.40627882 |
19 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.37668654 |
20 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 4.33000268 |
21 | adenosine receptor signaling pathway (GO:0001973) | 4.32118249 |
22 | layer formation in cerebral cortex (GO:0021819) | 4.28470897 |
23 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.17293714 |
24 | nucleobase catabolic process (GO:0046113) | 4.17046085 |
25 | glycine transport (GO:0015816) | 4.08851685 |
26 | regulation of platelet activation (GO:0010543) | 4.08510148 |
27 | negative regulation of appetite (GO:0032099) | 4.06434834 |
28 | negative regulation of response to food (GO:0032096) | 4.06434834 |
29 | regulation of glycogen (starch) synthase activity (GO:2000465) | 4.06368753 |
30 | protein neddylation (GO:0045116) | 4.05395267 |
31 | alanine transport (GO:0032328) | 4.04191628 |
32 | lipid particle organization (GO:0034389) | 3.96640748 |
33 | neutrophil activation involved in immune response (GO:0002283) | 3.95034297 |
34 | regulation of lipoprotein metabolic process (GO:0050746) | 3.92361165 |
35 | regulation of fatty acid oxidation (GO:0046320) | 3.90611787 |
36 | regulation of gonadotropin secretion (GO:0032276) | 3.84323637 |
37 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.84299743 |
38 | NADH metabolic process (GO:0006734) | 3.76899448 |
39 | regulation of synapse structural plasticity (GO:0051823) | 3.76470297 |
40 | biotin metabolic process (GO:0006768) | 3.75752934 |
41 | tricarboxylic acid cycle (GO:0006099) | 3.74857798 |
42 | blood coagulation, intrinsic pathway (GO:0007597) | 3.74729948 |
43 | angiogenesis involved in wound healing (GO:0060055) | 3.73255070 |
44 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.73126103 |
45 | carnitine transmembrane transport (GO:1902603) | 3.70375594 |
46 | positive regulation of fatty acid oxidation (GO:0046321) | 3.67842332 |
47 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.66761780 |
48 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 3.65419640 |
49 | synaptic vesicle maturation (GO:0016188) | 3.64771619 |
50 | negative regulation of heart rate (GO:0010459) | 3.63818999 |
51 | succinate metabolic process (GO:0006105) | 3.63609087 |
52 | platelet aggregation (GO:0070527) | 3.63048589 |
53 | glycerolipid catabolic process (GO:0046503) | 3.56954893 |
54 | coenzyme A biosynthetic process (GO:0015937) | 3.52644583 |
55 | vocalization behavior (GO:0071625) | 3.52620822 |
56 | triglyceride biosynthetic process (GO:0019432) | 3.52159692 |
57 | regulation of cofactor metabolic process (GO:0051193) | 3.51647429 |
58 | regulation of coenzyme metabolic process (GO:0051196) | 3.51647429 |
59 | cellular response to epinephrine stimulus (GO:0071872) | 3.48038812 |
60 | megakaryocyte development (GO:0035855) | 3.45624984 |
61 | negative regulation of platelet activation (GO:0010544) | 3.44428854 |
62 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.44216513 |
63 | positive regulation of male gonad development (GO:2000020) | 3.42686063 |
64 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.41324087 |
65 | negative regulation of catecholamine secretion (GO:0033604) | 3.38358940 |
66 | negative regulation of neurotransmitter transport (GO:0051589) | 3.37954930 |
67 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.37421757 |
68 | positive regulation of glucose import (GO:0046326) | 3.36506429 |
69 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.33871814 |
70 | response to dietary excess (GO:0002021) | 3.32786331 |
71 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.29767748 |
72 | locomotory exploration behavior (GO:0035641) | 3.28454767 |
73 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.27804442 |
74 | phagocytosis, recognition (GO:0006910) | 3.27404046 |
75 | valine metabolic process (GO:0006573) | 3.26460428 |
76 | * activation of protein kinase A activity (GO:0034199) | 3.25626943 |
77 | acylglycerol biosynthetic process (GO:0046463) | 3.24500710 |
78 | neutral lipid biosynthetic process (GO:0046460) | 3.24500710 |
79 | neuron cell-cell adhesion (GO:0007158) | 3.23781840 |
80 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.23397049 |
81 | amino-acid betaine transport (GO:0015838) | 3.22563846 |
82 | carnitine transport (GO:0015879) | 3.22563846 |
83 | negative regulation of phagocytosis (GO:0050765) | 3.21499583 |
84 | prepulse inhibition (GO:0060134) | 3.21495554 |
85 | definitive hemopoiesis (GO:0060216) | 3.19983273 |
86 | lipid storage (GO:0019915) | 3.16847089 |
87 | regulation of cholesterol storage (GO:0010885) | 3.16206501 |
88 | dopamine receptor signaling pathway (GO:0007212) | 3.15541782 |
89 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.14152240 |
90 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.13640500 |
91 | negative regulation of heart contraction (GO:0045822) | 3.13079846 |
92 | regulation of protein kinase A signaling (GO:0010738) | 3.12689600 |
93 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.12343210 |
94 | intracellular lipid transport (GO:0032365) | 3.10988186 |
95 | platelet formation (GO:0030220) | 3.10456992 |
96 | fatty acid elongation (GO:0030497) | 3.09529135 |
97 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.09273863 |
98 | exploration behavior (GO:0035640) | 3.07570185 |
99 | positive regulation of receptor recycling (GO:0001921) | 3.06692667 |
100 | regulation of synaptic vesicle transport (GO:1902803) | 3.06657387 |
101 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 3.06054885 |
102 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 3.05180109 |
103 | positive regulation of mast cell activation (GO:0033005) | 3.04664495 |
104 | response to epinephrine (GO:0071871) | 3.03280228 |
105 | dendritic spine morphogenesis (GO:0060997) | 3.02877487 |
106 | negative regulation of amino acid transport (GO:0051956) | 3.02573667 |
107 | linoleic acid metabolic process (GO:0043651) | 3.00598860 |
108 | negative regulation of adherens junction organization (GO:1903392) | 2.99160248 |
109 | negative regulation of focal adhesion assembly (GO:0051895) | 2.99160248 |
110 | negative regulation of cell junction assembly (GO:1901889) | 2.99160248 |
111 | positive regulation of muscle hypertrophy (GO:0014742) | 2.99041996 |
112 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.99041996 |
113 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.97986739 |
114 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.97320640 |
115 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.97254322 |
116 | regulation of female receptivity (GO:0045924) | 2.97173628 |
117 | synaptic vesicle exocytosis (GO:0016079) | 2.97054710 |
118 | positive regulation of glucose transport (GO:0010828) | 2.96224340 |
119 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.96192711 |
120 | negative regulation of blood circulation (GO:1903523) | 2.95177619 |
121 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.94354127 |
122 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.93078617 |
123 | clathrin coat assembly (GO:0048268) | 2.92737305 |
124 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.92231581 |
125 | response to leptin (GO:0044321) | 2.91657252 |
126 | protein localization to synapse (GO:0035418) | 2.91548815 |
127 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.90447896 |
128 | negative regulation of amine transport (GO:0051953) | 2.90188181 |
129 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.88472396 |
130 | cellular response to monoamine stimulus (GO:0071868) | 2.86662878 |
131 | cellular response to catecholamine stimulus (GO:0071870) | 2.86662878 |
132 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.84689653 |
133 | mating behavior (GO:0007617) | 2.83972738 |
134 | negative regulation of macrophage differentiation (GO:0045650) | 2.83054979 |
135 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.82715029 |
136 | myeloid cell development (GO:0061515) | 2.82253056 |
137 | regulation of homotypic cell-cell adhesion (GO:0034110) | 2.81199352 |
138 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 2.80690050 |
139 | striatum development (GO:0021756) | 2.80616660 |
140 | response to nerve growth factor (GO:1990089) | 2.80393313 |
141 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.80393313 |
142 | tricarboxylic acid metabolic process (GO:0072350) | 2.79659423 |
143 | regulation of response to food (GO:0032095) | 2.79120074 |
144 | positive regulation of fibroblast migration (GO:0010763) | 2.78993324 |
145 | fatty acid homeostasis (GO:0055089) | 2.77431877 |
146 | hemoglobin metabolic process (GO:0020027) | 2.77165293 |
147 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.77144216 |
148 | regulation of sulfur metabolic process (GO:0042762) | 2.76743840 |
149 | response to monoamine (GO:0071867) | 2.76655886 |
150 | response to catecholamine (GO:0071869) | 2.76655886 |
151 | regulation of erythrocyte differentiation (GO:0045646) | 2.76505538 |
152 | positive regulation of filopodium assembly (GO:0051491) | 2.75355496 |
153 | androgen biosynthetic process (GO:0006702) | 2.75190881 |
154 | thioester biosynthetic process (GO:0035384) | 2.75146086 |
155 | acyl-CoA biosynthetic process (GO:0071616) | 2.75146086 |
156 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 2.74802299 |
157 | fatty acid beta-oxidation (GO:0006635) | 2.74745878 |
158 | axon extension (GO:0048675) | 2.74721398 |
159 | cerebellar granule cell differentiation (GO:0021707) | 2.72215274 |
160 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.70722396 |
161 | cell migration in hindbrain (GO:0021535) | 2.69966243 |
162 | cellular response to leptin stimulus (GO:0044320) | 2.69862689 |
163 | ovulation from ovarian follicle (GO:0001542) | 2.68960982 |
164 | response to cold (GO:0009409) | 2.66131669 |
165 | gas transport (GO:0015669) | 2.65011111 |
166 | positive regulation of synapse maturation (GO:0090129) | 2.64886243 |
167 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.64536401 |
168 | response to insecticide (GO:0017085) | 2.64332943 |
169 | phosphatidic acid biosynthetic process (GO:0006654) | 2.63139091 |
170 | phosphatidic acid metabolic process (GO:0046473) | 2.63139091 |
171 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.63115063 |
172 | glycerol metabolic process (GO:0006071) | 2.62697140 |
173 | oxygen transport (GO:0015671) | 2.62684708 |
174 | regulation of norepinephrine secretion (GO:0014061) | 2.62364332 |
175 | axon cargo transport (GO:0008088) | 2.61627245 |
176 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.61053327 |
177 | protein heterotrimerization (GO:0070208) | 2.61034832 |
178 | relaxation of smooth muscle (GO:0044557) | 2.60823589 |
179 | positive regulation of histone deacetylation (GO:0031065) | 2.60695860 |
180 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.60406794 |
181 | dendrite morphogenesis (GO:0048813) | 2.60368935 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 9.38798455 |
2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.78431112 |
3 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.08638661 |
4 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.99076288 |
5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.71976397 |
6 | * GBX2_23144817_ChIP-Seq_PC3_Human | 2.57923309 |
7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.47249171 |
8 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.40961450 |
9 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.40396480 |
10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.38221391 |
11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.38221391 |
12 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.29099145 |
13 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.26010367 |
14 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.24724610 |
15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.23056071 |
16 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.21859266 |
17 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.18708301 |
18 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.06167952 |
19 | GATA1_22025678_ChIP-Seq_K562_Human | 2.05994926 |
20 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00894062 |
21 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.00705735 |
22 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.99186530 |
23 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.99016794 |
24 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.98435880 |
25 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.94568271 |
26 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.92318110 |
27 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.88428944 |
28 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.86335112 |
29 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.83353548 |
30 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.78274832 |
31 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.72459004 |
32 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.71249241 |
33 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.70564299 |
34 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.69321371 |
35 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.68111383 |
36 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.65260646 |
37 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.54730136 |
38 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.52012531 |
39 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.47514554 |
40 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.46918024 |
41 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.45039364 |
42 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.44879073 |
43 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.44516582 |
44 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.43732635 |
45 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.43135753 |
46 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.42718937 |
47 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.42488707 |
48 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.41452717 |
49 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.40140638 |
50 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.36777449 |
51 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.36004233 |
52 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.35656010 |
53 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.35045043 |
54 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.34679519 |
55 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.34424028 |
56 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.34355773 |
57 | AR_25329375_ChIP-Seq_VCAP_Human | 1.32788581 |
58 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.31969334 |
59 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.30450235 |
60 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.30256550 |
61 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.29378595 |
62 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.27946172 |
63 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.27811541 |
64 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.27449035 |
65 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.26306631 |
66 | KDM2B_26808549_Chip-Seq_K562_Human | 1.25004485 |
67 | VDR_22108803_ChIP-Seq_LS180_Human | 1.24667843 |
68 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.24181677 |
69 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24118366 |
70 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.23522418 |
71 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.23413355 |
72 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.22537790 |
73 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.22329722 |
74 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.20191524 |
75 | EWS_26573619_Chip-Seq_HEK293_Human | 1.19068183 |
76 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.18332515 |
77 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.18234657 |
78 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16852910 |
79 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.16622313 |
80 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.16382636 |
81 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.16382636 |
82 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.16074798 |
83 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.14530717 |
84 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.14034696 |
85 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.13200849 |
86 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.12993488 |
87 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.10518722 |
88 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10518722 |
89 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.10045065 |
90 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.09995633 |
91 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09878797 |
92 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.09295840 |
93 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.09139313 |
94 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.08087748 |
95 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.07701266 |
96 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.07495422 |
97 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.07495422 |
98 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.05612273 |
99 | TCF4_23295773_ChIP-Seq_U87_Human | 1.05075017 |
100 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.04951025 |
101 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04934505 |
102 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.03896497 |
103 | RXR_22108803_ChIP-Seq_LS180_Human | 1.03521316 |
104 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.03264771 |
105 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.03193115 |
106 | GF1_26923725_Chip-Seq_HPCs_Mouse | 1.03037002 |
107 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.02662474 |
108 | GATA2_19941826_ChIP-Seq_K562_Human | 1.02150516 |
109 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.01112822 |
110 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.01077197 |
111 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.00681815 |
112 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.00597809 |
113 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.99817790 |
114 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.99153665 |
115 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.98858777 |
116 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.98822900 |
117 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.98045247 |
118 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.97253838 |
119 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.96139150 |
120 | TBL1_22424771_ChIP-Seq_293T_Human | 0.95039829 |
121 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94999869 |
122 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.94811234 |
123 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94601846 |
124 | * IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.94495258 |
125 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.93958331 |
126 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.93851043 |
127 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.93342467 |
128 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.93075815 |
129 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.89637629 |
130 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.89596336 |
131 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.89364078 |
132 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.88653671 |
133 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.88337783 |
134 | JUN_21703547_ChIP-Seq_K562_Human | 0.87835640 |
135 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.87230744 |
136 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.86369318 |
137 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.86367523 |
138 | AR_19668381_ChIP-Seq_PC3_Human | 0.85922157 |
139 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.85613817 |
140 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.84792312 |
141 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.83717101 |
142 | P300_19829295_ChIP-Seq_ESCs_Human | 0.83500651 |
143 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.81580454 |
144 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.81194030 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005464_abnormal_platelet_physiology | 5.84338208 |
2 | MP0005670_abnormal_white_adipose | 5.31103269 |
3 | MP0008004_abnormal_stomach_pH | 4.93597665 |
4 | MP0004130_abnormal_muscle_cell | 4.38060322 |
5 | MP0005666_abnormal_adipose_tissue | 3.81909874 |
6 | MP0004859_abnormal_synaptic_plasticity | 3.53221627 |
7 | MP0004185_abnormal_adipocyte_glucose | 3.19730757 |
8 | MP0003724_increased_susceptibility_to | 3.12059254 |
9 | MP0005375_adipose_tissue_phenotype | 2.81906959 |
10 | MP0000013_abnormal_adipose_tissue | 2.77066978 |
11 | MP0002909_abnormal_adrenal_gland | 2.74157080 |
12 | MP0003828_pulmonary_edema | 2.70709047 |
13 | MP0002971_abnormal_brown_adipose | 2.58815318 |
14 | MP0002837_dystrophic_cardiac_calcinosis | 2.51452002 |
15 | MP0004084_abnormal_cardiac_muscle | 2.49895436 |
16 | MP0004270_analgesia | 2.41344843 |
17 | MP0001968_abnormal_touch/_nociception | 2.38690221 |
18 | MP0000465_gastrointestinal_hemorrhage | 2.34807933 |
19 | MP0003635_abnormal_synaptic_transmissio | 2.30205941 |
20 | MP0004147_increased_porphyrin_level | 2.27288812 |
21 | MP0000003_abnormal_adipose_tissue | 2.10788736 |
22 | MP0006276_abnormal_autonomic_nervous | 2.09605789 |
23 | MP0002733_abnormal_thermal_nociception | 2.08971806 |
24 | * MP0005535_abnormal_body_temperature | 2.07860045 |
25 | MP0003011_delayed_dark_adaptation | 2.07644644 |
26 | MP0002876_abnormal_thyroid_physiology | 2.06056018 |
27 | MP0002735_abnormal_chemical_nociception | 2.06053793 |
28 | MP0008438_abnormal_cutaneous_collagen | 2.00673474 |
29 | MP0002734_abnormal_mechanical_nocicepti | 1.98773909 |
30 | MP0005083_abnormal_biliary_tract | 1.98749923 |
31 | MP0005334_abnormal_fat_pad | 1.95211065 |
32 | MP0009780_abnormal_chondrocyte_physiolo | 1.93559909 |
33 | MP0009115_abnormal_fat_cell | 1.88823413 |
34 | MP0002063_abnormal_learning/memory/cond | 1.87973104 |
35 | MP0001348_abnormal_lacrimal_gland | 1.81984891 |
36 | * MP0002970_abnormal_white_adipose | 1.79069896 |
37 | MP0002736_abnormal_nociception_after | 1.77398594 |
38 | MP0008995_early_reproductive_senescence | 1.71958035 |
39 | MP0000343_altered_response_to | 1.65857476 |
40 | MP0005386_behavior/neurological_phenoty | 1.65322122 |
41 | MP0004924_abnormal_behavior | 1.65322122 |
42 | MP0001970_abnormal_pain_threshold | 1.63270544 |
43 | MP0003880_abnormal_central_pattern | 1.62622323 |
44 | MP0004510_myositis | 1.58753642 |
45 | MP0001501_abnormal_sleep_pattern | 1.54689814 |
46 | MP0000569_abnormal_digit_pigmentation | 1.51725363 |
47 | MP0003959_abnormal_lean_body | 1.49466492 |
48 | * MP0009745_abnormal_behavioral_response | 1.49455797 |
49 | MP0008877_abnormal_DNA_methylation | 1.47210621 |
50 | MP0004036_abnormal_muscle_relaxation | 1.46775743 |
51 | MP0003221_abnormal_cardiomyocyte_apopto | 1.45313717 |
52 | MP0003122_maternal_imprinting | 1.44942269 |
53 | MP0004811_abnormal_neuron_physiology | 1.40149779 |
54 | MP0005423_abnormal_somatic_nervous | 1.39675385 |
55 | MP0003646_muscle_fatigue | 1.38241021 |
56 | MP0005167_abnormal_blood-brain_barrier | 1.37677214 |
57 | MP0002572_abnormal_emotion/affect_behav | 1.35236094 |
58 | MP0002332_abnormal_exercise_endurance | 1.34494512 |
59 | * MP0005448_abnormal_energy_balance | 1.32841297 |
60 | * MP0005452_abnormal_adipose_tissue | 1.31715911 |
61 | MP0003656_abnormal_erythrocyte_physiolo | 1.30659563 |
62 | MP0008872_abnormal_physiological_respon | 1.28135247 |
63 | MP0009046_muscle_twitch | 1.25457252 |
64 | MP0000778_abnormal_nervous_system | 1.25019908 |
65 | MP0001486_abnormal_startle_reflex | 1.22493358 |
66 | MP0005645_abnormal_hypothalamus_physiol | 1.18186829 |
67 | MP0004858_abnormal_nervous_system | 1.17916291 |
68 | MP0003787_abnormal_imprinting | 1.15051435 |
69 | MP0006036_abnormal_mitochondrial_physio | 1.14422715 |
70 | MP0001879_abnormal_lymphatic_vessel | 1.14143105 |
71 | MP0002064_seizures | 1.13968755 |
72 | MP0003329_amyloid_beta_deposits | 1.13406878 |
73 | * MP0002078_abnormal_glucose_homeostasis | 1.13303955 |
74 | MP0002272_abnormal_nervous_system | 1.12247680 |
75 | MP0002184_abnormal_innervation | 1.12021643 |
76 | MP0002067_abnormal_sensory_capabilities | 1.08547946 |
77 | MP0001545_abnormal_hematopoietic_system | 1.07718916 |
78 | MP0005397_hematopoietic_system_phenotyp | 1.07718916 |
79 | MP0004085_abnormal_heartbeat | 1.07221436 |
80 | MP0008961_abnormal_basal_metabolism | 1.05916116 |
81 | MP0004484_altered_response_of | 1.03318028 |
82 | MP0001440_abnormal_grooming_behavior | 1.02464658 |
83 | MP0001851_eye_inflammation | 1.01931021 |
84 | MP0003186_abnormal_redox_activity | 1.00447227 |
85 | MP0003123_paternal_imprinting | 0.99572083 |
86 | MP0002972_abnormal_cardiac_muscle | 0.99303877 |
87 | MP0002638_abnormal_pupillary_reflex | 0.98985484 |
88 | MP0001661_extended_life_span | 0.98072153 |
89 | * MP0010329_abnormal_lipoprotein_level | 0.97223259 |
90 | MP0003121_genomic_imprinting | 0.96433312 |
91 | MP0000639_abnormal_adrenal_gland | 0.96033758 |
92 | MP0001177_atelectasis | 0.96022887 |
93 | MP0001188_hyperpigmentation | 0.95969865 |
94 | MP0005409_darkened_coat_color | 0.95665322 |
95 | MP0000751_myopathy | 0.94874683 |
96 | MP0008569_lethality_at_weaning | 0.93687018 |
97 | MP0008775_abnormal_heart_ventricle | 0.92991230 |
98 | MP0005275_abnormal_skin_tensile | 0.92036091 |
99 | * MP0002118_abnormal_lipid_homeostasis | 0.90906728 |
100 | MP0003283_abnormal_digestive_organ | 0.87210915 |
101 | MP0004215_abnormal_myocardial_fiber | 0.86230548 |
102 | MP0003948_abnormal_gas_homeostasis | 0.85624451 |
103 | MP0001529_abnormal_vocalization | 0.84917643 |
104 | MP0002557_abnormal_social/conspecific_i | 0.83533821 |
105 | MP0000955_abnormal_spinal_cord | 0.82352034 |
106 | * MP0002069_abnormal_eating/drinking_beha | 0.82048965 |
107 | MP0003890_abnormal_embryonic-extraembry | 0.81680027 |
108 | * MP0003953_abnormal_hormone_level | 0.80404647 |
109 | MP0005620_abnormal_muscle_contractility | 0.80356399 |
110 | MP0005084_abnormal_gallbladder_morpholo | 0.79457001 |
111 | MP0005646_abnormal_pituitary_gland | 0.79044122 |
112 | MP0000759_abnormal_skeletal_muscle | 0.78594062 |
113 | * MP0002066_abnormal_motor_capabilities/c | 0.78302519 |
114 | MP0003638_abnormal_response/metabolism_ | 0.75535889 |
115 | MP0001986_abnormal_taste_sensitivity | 0.75433757 |
116 | MP0002822_catalepsy | 0.74388478 |
117 | MP0008874_decreased_physiological_sensi | 0.74104570 |
118 | MP0000249_abnormal_blood_vessel | 0.74036142 |
119 | MP0003566_abnormal_cell_adhesion | 0.73601324 |
120 | MP0003633_abnormal_nervous_system | 0.73399444 |
121 | MP0005647_abnormal_sex_gland | 0.72258099 |
122 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.70616629 |
123 | MP0005187_abnormal_penis_morphology | 0.70035851 |
124 | MP0003690_abnormal_glial_cell | 0.67089929 |
125 | MP0002128_abnormal_blood_circulation | 0.66645414 |
126 | MP0004145_abnormal_muscle_electrophysio | 0.65708968 |
127 | MP0002882_abnormal_neuron_morphology | 0.64418810 |
128 | MP0002132_abnormal_respiratory_system | 0.64382404 |
129 | MP0005385_cardiovascular_system_phenoty | 0.63311169 |
130 | MP0001544_abnormal_cardiovascular_syste | 0.63311169 |
131 | MP0006138_congestive_heart_failure | 0.63294076 |
132 | MP0004142_abnormal_muscle_tone | 0.62307749 |
133 | MP0000230_abnormal_systemic_arterial | 0.61107266 |
134 | MP0003303_peritoneal_inflammation | 0.60484469 |
135 | MP0002152_abnormal_brain_morphology | 0.58570823 |
136 | MP0004087_abnormal_muscle_fiber | 0.58328324 |
137 | MP0003879_abnormal_hair_cell | 0.57042142 |
138 | MP0004233_abnormal_muscle_weight | 0.57021641 |
139 | MP0000681_abnormal_thyroid_gland | 0.56384005 |
140 | MP0001727_abnormal_embryo_implantation | 0.55506747 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Prolonged bleeding time (HP:0003010) | 9.81867090 |
2 | Increased mean platelet volume (HP:0011877) | 9.33031616 |
3 | Abnormal platelet volume (HP:0011876) | 8.67738165 |
4 | Menorrhagia (HP:0000132) | 7.89675039 |
5 | Petechiae (HP:0000967) | 6.80976553 |
6 | Purpura (HP:0000979) | 6.32817784 |
7 | Oligomenorrhea (HP:0000876) | 5.76050967 |
8 | Epistaxis (HP:0000421) | 5.49369380 |
9 | Poikilocytosis (HP:0004447) | 5.05133800 |
10 | Impaired platelet aggregation (HP:0003540) | 4.87089633 |
11 | Abnormal platelet function (HP:0011869) | 4.87089633 |
12 | Gingival bleeding (HP:0000225) | 4.50422217 |
13 | Hyperlipoproteinemia (HP:0010980) | 4.42245213 |
14 | Spontaneous hematomas (HP:0007420) | 4.09168030 |
15 | Acanthocytosis (HP:0001927) | 4.03852300 |
16 | Papilledema (HP:0001085) | 3.91046266 |
17 | Gonadal dysgenesis (HP:0000133) | 3.68259885 |
18 | Poor eye contact (HP:0000817) | 3.68188045 |
19 | Polycythemia (HP:0001901) | 3.51307640 |
20 | Enlarged penis (HP:0000040) | 3.48382354 |
21 | Progressive inability to walk (HP:0002505) | 3.45685646 |
22 | Acanthosis nigricans (HP:0000956) | 3.32374410 |
23 | Abnormal social behavior (HP:0012433) | 3.31775085 |
24 | Impaired social interactions (HP:0000735) | 3.31775085 |
25 | Papillary thyroid carcinoma (HP:0002895) | 3.30758761 |
26 | Myokymia (HP:0002411) | 3.29182513 |
27 | Myoglobinuria (HP:0002913) | 3.24711041 |
28 | Hypertriglyceridemia (HP:0002155) | 3.12114387 |
29 | Pheochromocytoma (HP:0002666) | 3.07947632 |
30 | Visual hallucinations (HP:0002367) | 2.99474543 |
31 | Abnormal eating behavior (HP:0100738) | 2.96794628 |
32 | Polyphagia (HP:0002591) | 2.90696881 |
33 | Macroorchidism (HP:0000053) | 2.90513386 |
34 | Focal seizures (HP:0007359) | 2.90299129 |
35 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.86150470 |
36 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.81768979 |
37 | Abnormality of alanine metabolism (HP:0010916) | 2.81768979 |
38 | Hyperalaninemia (HP:0003348) | 2.81768979 |
39 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.77539406 |
40 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.77539406 |
41 | Neuroendocrine neoplasm (HP:0100634) | 2.76482217 |
42 | Limb dystonia (HP:0002451) | 2.74942313 |
43 | Conjunctival telangiectasia (HP:0000524) | 2.73364952 |
44 | Focal motor seizures (HP:0011153) | 2.72401180 |
45 | Hypercortisolism (HP:0001578) | 2.70700175 |
46 | Hyperthyroidism (HP:0000836) | 2.68034940 |
47 | Mutism (HP:0002300) | 2.67746326 |
48 | Insidious onset (HP:0003587) | 2.64940143 |
49 | Termporal pattern (HP:0011008) | 2.64940143 |
50 | Gonadotropin excess (HP:0000837) | 2.62429579 |
51 | Growth hormone excess (HP:0000845) | 2.61516742 |
52 | Abnormal hemoglobin (HP:0011902) | 2.59109417 |
53 | Increased muscle lipid content (HP:0009058) | 2.55646491 |
54 | Paralysis (HP:0003470) | 2.55519934 |
55 | Resting tremor (HP:0002322) | 2.52232679 |
56 | Difficulty running (HP:0009046) | 2.51297159 |
57 | Male infertility (HP:0003251) | 2.49124586 |
58 | Insomnia (HP:0100785) | 2.48958950 |
59 | Hyperpituitarism (HP:0010514) | 2.46292845 |
60 | Ventricular fibrillation (HP:0001663) | 2.45929844 |
61 | Relative macrocephaly (HP:0004482) | 2.45271605 |
62 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.44289354 |
63 | Postural instability (HP:0002172) | 2.43707041 |
64 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.38686945 |
65 | Conjunctival hamartoma (HP:0100780) | 2.36903636 |
66 | Bruising susceptibility (HP:0000978) | 2.35590695 |
67 | Truncus arteriosus (HP:0001660) | 2.32395441 |
68 | Truncal ataxia (HP:0002078) | 2.31983691 |
69 | Anomalous pulmonary venous return (HP:0010772) | 2.30410893 |
70 | Torticollis (HP:0000473) | 2.29935636 |
71 | Atonic seizures (HP:0010819) | 2.26598709 |
72 | Inappropriate behavior (HP:0000719) | 2.26028209 |
73 | Increased variability in muscle fiber diameter (HP:0003557) | 2.25713112 |
74 | Action tremor (HP:0002345) | 2.25496683 |
75 | Abnormality of the corticospinal tract (HP:0002492) | 2.25163150 |
76 | Anxiety (HP:0000739) | 2.22851300 |
77 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.22807610 |
78 | Thyroid carcinoma (HP:0002890) | 2.22776240 |
79 | Ankle clonus (HP:0011448) | 2.20263214 |
80 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.20013167 |
81 | Testicular neoplasm (HP:0010788) | 2.19250158 |
82 | Depression (HP:0000716) | 2.18747454 |
83 | Amyotrophic lateral sclerosis (HP:0007354) | 2.18310960 |
84 | Drooling (HP:0002307) | 2.18289045 |
85 | Excessive salivation (HP:0003781) | 2.18289045 |
86 | Epileptic encephalopathy (HP:0200134) | 2.18033641 |
87 | Supranuclear gaze palsy (HP:0000605) | 2.17029853 |
88 | Hyperacusis (HP:0010780) | 2.16514022 |
89 | Increased density of long bones (HP:0006392) | 2.16298828 |
90 | Neoplasm of the adrenal gland (HP:0100631) | 2.15682353 |
91 | Focal dystonia (HP:0004373) | 2.15176509 |
92 | Craniofacial dystonia (HP:0012179) | 2.15004803 |
93 | Diminished motivation (HP:0000745) | 2.14946469 |
94 | Agitation (HP:0000713) | 2.13801069 |
95 | Generalized tonic-clonic seizures (HP:0002069) | 2.11997324 |
96 | Febrile seizures (HP:0002373) | 2.10626337 |
97 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.09617129 |
98 | Bone cyst (HP:0012062) | 2.09545338 |
99 | Hamartoma of the eye (HP:0010568) | 2.08892241 |
100 | Inability to walk (HP:0002540) | 2.07219082 |
101 | Menstrual irregularities (HP:0000858) | 2.06209409 |
102 | Dyschromatopsia (HP:0007641) | 2.03900591 |
103 | Large hands (HP:0001176) | 2.02619450 |
104 | Lower limb muscle weakness (HP:0007340) | 2.01674178 |
105 | Buphthalmos (HP:0000557) | 2.01125515 |
106 | Abnormality of the vocal cords (HP:0008777) | 2.01001216 |
107 | Bradykinesia (HP:0002067) | 2.00054768 |
108 | Hypoventilation (HP:0002791) | 1.99928519 |
109 | Long foot (HP:0001833) | 1.99784077 |
110 | Abnormality of the common coagulation pathway (HP:0010990) | 1.97194632 |
111 | Scanning speech (HP:0002168) | 1.96865664 |
112 | Pachygyria (HP:0001302) | 1.93986695 |
113 | Nausea (HP:0002018) | 1.93614028 |
114 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.93114257 |
115 | Abnormality of the pulmonary veins (HP:0011718) | 1.93011865 |
116 | Urinary urgency (HP:0000012) | 1.92889473 |
117 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.92576952 |
118 | Rhabdomyolysis (HP:0003201) | 1.92233723 |
119 | Large earlobe (HP:0009748) | 1.91712073 |
120 | Hyperglycinuria (HP:0003108) | 1.90623922 |
121 | Abnormal large intestine physiology (HP:0012700) | 1.90390785 |
122 | Reticulocytosis (HP:0001923) | 1.89770341 |
123 | Neonatal hypoglycemia (HP:0001998) | 1.89708330 |
124 | Sex reversal (HP:0012245) | 1.89705756 |
125 | Abnormal sex determination (HP:0012244) | 1.89705756 |
126 | Progressive microcephaly (HP:0000253) | 1.88578106 |
127 | Abnormality of pain sensation (HP:0010832) | 1.85374651 |
128 | Impaired pain sensation (HP:0007328) | 1.85374651 |
129 | Dysmetric saccades (HP:0000641) | 1.85338627 |
130 | Abnormal pupillary function (HP:0007686) | 1.83394846 |
131 | Accelerated skeletal maturation (HP:0005616) | 1.82773799 |
132 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.82322390 |
133 | Upper limb muscle weakness (HP:0003484) | 1.82156008 |
134 | Osteomalacia (HP:0002749) | 1.82012369 |
135 | Tinnitus (HP:0000360) | 1.81085432 |
136 | Hepatic necrosis (HP:0002605) | 1.80596465 |
137 | Bowel incontinence (HP:0002607) | 1.80593268 |
138 | Amblyopia (HP:0000646) | 1.79725347 |
139 | Lymphangioma (HP:0100764) | 1.79534366 |
140 | Broad-based gait (HP:0002136) | 1.78377227 |
141 | Cortical dysplasia (HP:0002539) | 1.77363833 |
142 | Nasal polyposis (HP:0100582) | 1.76083032 |
143 | Ileus (HP:0002595) | 1.75644461 |
144 | Facial diplegia (HP:0001349) | 1.74920921 |
145 | Bowel diverticulosis (HP:0005222) | 1.74264352 |
146 | Abnormality of binocular vision (HP:0011514) | 1.73468730 |
147 | Diplopia (HP:0000651) | 1.73468730 |
148 | Abnormal hair whorl (HP:0010721) | 1.72445251 |
149 | Complete atrioventricular canal defect (HP:0001674) | 1.71053318 |
150 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.69420121 |
151 | Precocious puberty (HP:0000826) | 1.69185532 |
152 | Acute myeloid leukemia (HP:0004808) | 1.68937934 |
153 | Hyperventilation (HP:0002883) | 1.67298082 |
154 | Absent/shortened dynein arms (HP:0200106) | 1.67186353 |
155 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.67186353 |
156 | Muscle fiber splitting (HP:0003555) | 1.65903172 |
157 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.65461049 |
158 | Abnormality of lateral ventricle (HP:0030047) | 1.64280450 |
159 | Myocardial infarction (HP:0001658) | 1.63915969 |
160 | Spastic gait (HP:0002064) | 1.59786742 |
161 | Atrioventricular canal defect (HP:0006695) | 1.59289007 |
162 | Cerebral hemorrhage (HP:0001342) | 1.58582318 |
163 | Failure to thrive in infancy (HP:0001531) | 1.56320623 |
164 | Male pseudohermaphroditism (HP:0000037) | 1.51006736 |
165 | Back pain (HP:0003418) | 1.50986329 |
166 | Delayed puberty (HP:0000823) | 1.46314080 |
167 | Rimmed vacuoles (HP:0003805) | 1.45494564 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MARK1 | 5.07277020 |
2 | CAMK1D | 3.74325776 |
3 | TRIB3 | 3.72789878 |
4 | CAMK1G | 2.97059159 |
5 | NTRK3 | 2.84230439 |
6 | TEC | 2.55871078 |
7 | BMX | 2.51750580 |
8 | MINK1 | 2.48273451 |
9 | MAP3K9 | 2.42584527 |
10 | MAP3K4 | 2.26925123 |
11 | MAP2K7 | 2.17907952 |
12 | SCYL2 | 2.13287972 |
13 | MAP3K12 | 2.07927387 |
14 | PDK3 | 1.97443329 |
15 | PDK4 | 1.97443329 |
16 | KSR2 | 1.92205242 |
17 | MYLK | 1.74434706 |
18 | MAPK13 | 1.69996034 |
19 | BTK | 1.66087308 |
20 | PRPF4B | 1.64272476 |
21 | LATS2 | 1.61142561 |
22 | MAP3K2 | 1.58502839 |
23 | MAP3K6 | 1.57825989 |
24 | PHKG2 | 1.53747353 |
25 | PHKG1 | 1.53747353 |
26 | DAPK2 | 1.51353294 |
27 | PNCK | 1.50966318 |
28 | RET | 1.49891866 |
29 | FRK | 1.48131997 |
30 | CAMKK2 | 1.47459279 |
31 | CDK5 | 1.46659504 |
32 | BMPR2 | 1.45477084 |
33 | KSR1 | 1.44952163 |
34 | DAPK1 | 1.44378040 |
35 | DYRK2 | 1.43714894 |
36 | MAP2K4 | 1.43169652 |
37 | NTRK2 | 1.39787350 |
38 | STK3 | 1.34069632 |
39 | NTRK1 | 1.32189133 |
40 | PAK6 | 1.30085638 |
41 | ERBB3 | 1.26197505 |
42 | LMTK2 | 1.26166871 |
43 | PTK2B | 1.23635121 |
44 | CAMKK1 | 1.23052991 |
45 | MST4 | 1.23027011 |
46 | CDK9 | 1.20913216 |
47 | SIK2 | 1.20092950 |
48 | PRKD3 | 1.20055054 |
49 | FGFR2 | 1.19656052 |
50 | YES1 | 1.14924144 |
51 | TAOK2 | 1.13336499 |
52 | RPS6KA2 | 1.11759484 |
53 | RIPK1 | 1.01937467 |
54 | BCKDK | 1.01872188 |
55 | MAP3K5 | 1.01544717 |
56 | MAP2K1 | 1.00835487 |
57 | FGFR3 | 0.99720991 |
58 | CSNK1G2 | 0.97766154 |
59 | PKN2 | 0.97503082 |
60 | FGR | 0.94503662 |
61 | GRK5 | 0.91140069 |
62 | SIK1 | 0.85265609 |
63 | DYRK1A | 0.82623656 |
64 | TAOK3 | 0.81067595 |
65 | HCK | 0.79509235 |
66 | PRKCH | 0.79083515 |
67 | ILK | 0.78162947 |
68 | PAK1 | 0.77559560 |
69 | PDGFRA | 0.76602051 |
70 | MUSK | 0.76120308 |
71 | EPHA4 | 0.75826977 |
72 | PRKAA2 | 0.75632477 |
73 | NLK | 0.75066483 |
74 | EEF2K | 0.74331910 |
75 | DYRK3 | 0.73245177 |
76 | PDK1 | 0.73222028 |
77 | PINK1 | 0.72023042 |
78 | PIK3CG | 0.70237564 |
79 | MARK2 | 0.70202318 |
80 | PDPK1 | 0.69939355 |
81 | CDK14 | 0.67621804 |
82 | RPS6KB1 | 0.67388428 |
83 | PRKG1 | 0.65621579 |
84 | SGK3 | 0.65588818 |
85 | TAOK1 | 0.64974946 |
86 | STK11 | 0.64751113 |
87 | STK4 | 0.64511254 |
88 | ARAF | 0.63192732 |
89 | PRKAA1 | 0.62803864 |
90 | PKN1 | 0.62036271 |
91 | ADRBK1 | 0.61571652 |
92 | TIE1 | 0.61177629 |
93 | EPHA3 | 0.60721808 |
94 | CAMK1 | 0.60591838 |
95 | DMPK | 0.60355852 |
96 | STK24 | 0.59021079 |
97 | SGK2 | 0.57765069 |
98 | CASK | 0.57000401 |
99 | FES | 0.55759840 |
100 | MAPK4 | 0.54917629 |
101 | CSNK1G3 | 0.54559186 |
102 | PDK2 | 0.54382011 |
103 | CDK18 | 0.52860639 |
104 | PRKCZ | 0.52776450 |
105 | PDGFRB | 0.51910457 |
106 | UHMK1 | 0.51772972 |
107 | MAP3K1 | 0.51295810 |
108 | PAK3 | 0.50818249 |
109 | MAP2K3 | 0.49819451 |
110 | PLK2 | 0.49252185 |
111 | CDK15 | 0.49085605 |
112 | ZAP70 | 0.48575778 |
113 | CDK6 | 0.48399976 |
114 | ERBB2 | 0.47463869 |
115 | LYN | 0.47302110 |
116 | CCNB1 | 0.45834631 |
117 | ADRBK2 | 0.45833137 |
118 | MAPKAPK3 | 0.44260356 |
119 | LIMK1 | 0.44145700 |
120 | MAPK12 | 0.44096374 |
121 | EPHB2 | 0.43322323 |
122 | SGK223 | 0.42762327 |
123 | SGK494 | 0.42762327 |
124 | TNIK | 0.42583422 |
125 | * PRKACG | 0.42506313 |
126 | CAMK2A | 0.42448139 |
127 | JAK2 | 0.42417672 |
128 | CSNK1G1 | 0.42253804 |
129 | EIF2AK1 | 0.41129730 |
130 | ACVR1B | 0.40673586 |
131 | RAF1 | 0.40212009 |
132 | CDK11A | 0.40182575 |
133 | CDK19 | 0.40002278 |
134 | WNK1 | 0.39631162 |
135 | PRKCG | 0.39518405 |
136 | TYRO3 | 0.36353216 |
137 | JAK1 | 0.35986320 |
138 | GRK6 | 0.35707832 |
139 | HIPK2 | 0.35002610 |
140 | SGK1 | 0.34645297 |
141 | MAPK10 | 0.34596598 |
142 | ROCK1 | 0.34503238 |
143 | PRKCB | 0.34450716 |
144 | RIPK4 | 0.33988036 |
145 | * RPS6KA3 | 0.32829065 |
146 | SYK | 0.32364017 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.93426854 |
2 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 3.59593145 |
3 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 3.08211870 |
4 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.54777772 |
5 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.18073725 |
6 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.06832895 |
7 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.02779918 |
8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.83898686 |
9 | Renin secretion_Homo sapiens_hsa04924 | 1.81061749 |
10 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.80798368 |
11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.74157202 |
12 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.67704447 |
13 | Olfactory transduction_Homo sapiens_hsa04740 | 1.67434124 |
14 | Circadian entrainment_Homo sapiens_hsa04713 | 1.63348280 |
15 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.63189715 |
16 | Morphine addiction_Homo sapiens_hsa05032 | 1.60347434 |
17 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.59123869 |
18 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.57884521 |
19 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.56376125 |
20 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.55205673 |
21 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 1.53383338 |
22 | Long-term potentiation_Homo sapiens_hsa04720 | 1.51539495 |
23 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.49643518 |
24 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.46863806 |
25 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.42143775 |
26 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.41387013 |
27 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.40352118 |
28 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.39043889 |
29 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.38448458 |
30 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.38129934 |
31 | Salivary secretion_Homo sapiens_hsa04970 | 1.35807163 |
32 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.35676559 |
33 | GABAergic synapse_Homo sapiens_hsa04727 | 1.34457483 |
34 | Gap junction_Homo sapiens_hsa04540 | 1.26453262 |
35 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.22573370 |
36 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.22222046 |
37 | Nicotine addiction_Homo sapiens_hsa05033 | 1.20122089 |
38 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.19098072 |
39 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.18063227 |
40 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.17263595 |
41 | Glioma_Homo sapiens_hsa05214 | 1.15001218 |
42 | Cocaine addiction_Homo sapiens_hsa05030 | 1.13463231 |
43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.13351838 |
44 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.11136993 |
45 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.08496840 |
46 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.03792509 |
47 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.03589295 |
48 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.02051423 |
49 | Long-term depression_Homo sapiens_hsa04730 | 1.01977988 |
50 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.00819784 |
51 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.99822687 |
52 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.99753449 |
53 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.99627898 |
54 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.99571015 |
55 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.99259736 |
56 | Insulin resistance_Homo sapiens_hsa04931 | 0.98833678 |
57 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.97958203 |
58 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.97154568 |
59 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.95922473 |
60 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.95050027 |
61 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.95035029 |
62 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.93866363 |
63 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.93399620 |
64 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.92685888 |
65 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.89975072 |
66 | Endometrial cancer_Homo sapiens_hsa05213 | 0.89242893 |
67 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.86766319 |
68 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.86399783 |
69 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.84990112 |
70 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.84590852 |
71 | Parkinsons disease_Homo sapiens_hsa05012 | 0.80876997 |
72 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.80468516 |
73 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.78820292 |
74 | Platelet activation_Homo sapiens_hsa04611 | 0.78457045 |
75 | Insulin secretion_Homo sapiens_hsa04911 | 0.78293386 |
76 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.76300271 |
77 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.75158353 |
78 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.75149283 |
79 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.74479969 |
80 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.73377667 |
81 | Carbon metabolism_Homo sapiens_hsa01200 | 0.73042335 |
82 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.72301231 |
83 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.72042721 |
84 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.71774561 |
85 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.70837335 |
86 | Thyroid cancer_Homo sapiens_hsa05216 | 0.70117949 |
87 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.69757431 |
88 | Melanogenesis_Homo sapiens_hsa04916 | 0.69065080 |
89 | Taste transduction_Homo sapiens_hsa04742 | 0.67677169 |
90 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.67436480 |
91 | Alcoholism_Homo sapiens_hsa05034 | 0.66931367 |
92 | Colorectal cancer_Homo sapiens_hsa05210 | 0.65467735 |
93 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.65354263 |
94 | Axon guidance_Homo sapiens_hsa04360 | 0.65051738 |
95 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.64148732 |
96 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.62192217 |
97 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.60445308 |
98 | Alzheimers disease_Homo sapiens_hsa05010 | 0.58984780 |
99 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.57608853 |
100 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.56940411 |
101 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.55154469 |
102 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.54615461 |
103 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.54461755 |
104 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.53471491 |
105 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53449594 |
106 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.52026117 |
107 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.51783918 |
108 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.51655360 |
109 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.50751491 |
110 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.49195425 |
111 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.47941265 |
112 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.47868515 |
113 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.47451101 |
114 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.46597443 |
115 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44323324 |
116 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.43073583 |
117 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.42470141 |
118 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.42413916 |
119 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.41083248 |
120 | Endocytosis_Homo sapiens_hsa04144 | 0.39967801 |
121 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.38271411 |
122 | Melanoma_Homo sapiens_hsa05218 | 0.37815355 |
123 | Focal adhesion_Homo sapiens_hsa04510 | 0.37766330 |
124 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36746392 |
125 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.36708802 |